Skip to main content
    V

    VSee Health, Inc. (VSEE)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • PINK

    $0.33
    -0.14 (-29.79%)

    Market Cap: $1.28M

    Last updated: Nov 13, 2026 at 4:00 PM ET

    VSee Health, Inc. (VSEE) Financials: Revenue, Profit and Cash Flow

    Updated Jun 30, 2026. Financial statements from company filings, amounts in US dollars.

    VSee Health reported revenue of $14.62M for the fiscal year ended Dec 31, 2025, up 40.3% from the year before. That year, net income was -$14.71M with a net margin of -100.6%, operating cash flow was -$3.45M and free cash flow was -$3.48M. The quarter ended Jun 30, 2026 had revenue of $1.56M and net income of $847.27K.

    Revenue and Margins

    The operating margin was -65.6% in the fiscal year ended Dec 2025, the lowest of the 4 years shown with an operating margin. Over the 5 years to Dec 2025, revenue grew from $6.80M, a compound annual rate of 16.5%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$14.62M+40.3%50.3%-65.6%-100.6%
    Dec 2024$10.42M+80.7%68.9%-596.4%-553.7%
    Dec 2023$5.77MN/A66.5%-32.5%-64.6%
    Dec 2022$0-100.0%N/AN/AN/A
    Dec 2021$7.34M+7.8%80.7%3.4%6.5%
    Dec 2020$6.80MN/A80.3%5.9%3.8%
    Annual, fiscal years ended Dec 2020 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Jun 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Revenue$14.62M$10.42M$5.77M$0$7.34M$6.80M
    Cost of revenue$7.26M$3.24M$1.93M$0$1.41M$1.34M
    Gross profit$7.36M$7.18M$3.83M$0$5.92M$5.46M
    Operating income-$9.58M-$62.15M-$1.87M-$3.59M$252.28K$404.50K
    Net income-$14.71M-$57.70M-$3.73M-$3.24M$475.90K$258.88K
    EBITDA-$8.96M-$57.10M-$1.51MN/A$386.34K$404.50K
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$1.56M$3.16M$3.93M$3.98M$1.06M$3.32M$3.73M$3.35M$1.71M$1.62M$3.02M$1.45M
    Gross profit$206.15K$1.20M$1.83M$2.07M$615.04K$1.86M$2.38M$2.78M$777.00K$1.23M$2.04M$973.07K
    Operating income-$2.70M-$2.97M-$3.44M-$2.06M-$1.56M-$1.83M-$3.03M-$58.29M-$932.52K$104.06K-$280.51K-$274.36K
    Net income$847.27K-$2.60M-$7.85M-$289.75K-$2.61M-$3.96M-$3.21M-$53.92M-$666.10K$94.75K-$1.30M-$98.58K
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $1.90M by $3.15M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Total assets$22.41M$19.99M$805.79K$7.63M$117.94M$2.73M
    Current assets$8.37M$3.02M$802.13K$107.00K$1.22M$1.48M
    Cash and equivalents$5.05M$326.12K$118.73K$107.00K$760.01K$775.24K
    Total liabilities$16.96M$20.01M$5.11M$7.67M$4.55M$2.11M
    Short-term debt$1.31M$7.85M$923.00K$0$0$133.08K
    Long-term debt$593.94K$593.94K$0N/AN/AN/A
    Shareholder equity$5.45M-$18.49K-$3.97M-$7.43M-$3.33M$614.49K
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$16.73M$19.02M$22.41M$18.71M$18.21M$19.40M$19.99M$25.03M$78.99M$1.39M$1.37M$8.14M
    Total liabilities$9.14M$12.70M$16.96M$24.28M$23.95M$22.89M$20.01M$20.27M$24.18M$13.34M$12.35M$9.39M
    Cash and equivalents$454.15K$1.35M$5.27M$472.76K$291.60K$410.12K$326.12K$2.33M$1.11M$689.28K$1.86K$507
    Shareholder equity$7.59M$6.32M$5.45M-$5.58M-$5.74M-$3.50M-$18.49K$4.76M$54.81M-$13.23M-$10.98M-$9.15M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Operating cash flow-$3.45M-$5.79M-$632.60K-$1.39M-$600.11K$789.12K
    Capital expenditures$29.93K$55.27K$4.33K$3$3$0
    Free cash flow-$3.48M-$5.84M-$636.93K-$1.39M-$600.12K$789.12K
    Dividends paid$10.00K$0$0N/AN/AN/A
    Share repurchases$44$5.15KN/A$110.47MN/AN/A
    Investing cash flow-$29.93K-$26.14K-$4.33K$110.12M-$116.73MN/A
    Financing cash flow$8.42M$6.02M$525.00K-$109.38M$118.09M-$83.67K
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-$1.17M-$2.45M-$1.93M-$754.54K-$324.60K-$440.49K-$2.97M-$221.03K-$3.17M$579.29K-$109.16K-$48.79K
    Capital expenditures$73.25K$26.75K$7.15K$7.31K$11.87K$11.87K$4.76K$4.99K$36.77K$8.74K$1.65K$3
    Free cash flow-$1.25M-$2.48M-$1.93M-$761.85K-$336.47K-$452.37K-$2.98M-$226.03K-$3.21M$570.55K-$110.80K-$48.80K
    Last 12 quarters

    Frequently Asked Questions About VSEE

    What is VSee Health's annual revenue?

    VSee Health reported revenue of $14.62M for the fiscal year ended Dec 31, 2025.

    How fast is VSee Health's revenue growing?

    Revenue was up 40.3% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is VSee Health profitable?

    No. VSee Health reported net income of -$14.71M for the fiscal year ended Dec 31, 2025, with a net margin of -100.6%.

    How much free cash flow does VSEE generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$3.45M minus capital expenditures of $29.93K produced free cash flow of -$3.48M.

    How much debt does VSee Health have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $593.94K, short-term debt of $1.31M and cash and equivalents of $5.05M.